Trial Profile
A Phase 1, Open Label, Drug Interaction Study of the Pharmacokinetics of ASP015K and Tacrolimus After Separate and Concomitant Administration to Healthy Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Oct 2010
Price :
$35
*
At a glance
- Drugs Peficitinib (Primary) ; Tacrolimus; Tacrolimus
- Indications Graft-versus-host disease; Lupus nephritis; Rheumatoid arthritis; Transplant rejection; Ulcerative colitis
- Focus Pharmacokinetics
- 30 Sep 2010 Actual end date added to 1 Sep 2010 as reported by ClinicalTrials.gov.
- 30 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Sep 2010 New trial record